Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
James O'HaraLaura WarnerHannah FoxDavid HamiltonDavid MeiklePaul CounterAndrew RobsonRebecca GoranovaMuhammad Shahid IqbalCharles KellyMax RobinsonVinidh PaleriPublished in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2021)
Whilst TORS has become a common practice in the management of OPSCC in the UK, these are the first reported oncological outcomes. For selected patients, TORS with or without adjuvant therapy is an appropriate treatment modality.
Keyphrases
- squamous cell carcinoma
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- cross sectional
- primary care
- peritoneal dialysis
- prostate cancer
- rectal cancer
- adipose tissue
- metabolic syndrome
- patient reported outcomes
- lymph node metastasis
- quality improvement
- robot assisted
- replacement therapy
- glycemic control